Keith J. Kendall - CEO and President, Director at Aquestive Therapeutics, Inc.

Issuer-level insider activity

Role
CEO and President, Director
Issuer ticker
AQST on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Keith J. Kendall since 20 Sep 2025

Reported holdings for Keith J. Kendall in Aquestive Therapeutics, Inc.

Form 4 holding CEO and President, Director

Aquestive Therapeutics, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
375,000
Estimated value
Report date
10 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Keith J. Kendall in Aquestive Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .